Journal Mobile Options
Table of Contents
Vol. 113, No. 1-3, 1997
Issue release date: 1997
Section title: The Peter Dukor Memorial Symposium
Int Arch Allergy Immunol 1997;113:30–34
(DOI:10.1159/000237500)

Fc Epsilon Rl on Human Epidermal Langerhans Cells: An Old Receptor with New Structure and Functions

Bieber T.
Department of Dermatology, Ludwig-Maximilians University, Munich, Germany

Do you have an account?

Register and profit from personalized services (MyKarger) Login Information

Please create your User ID & Password





Contact Information









I have read the Karger Terms and Conditions and agree.

Register and profit from personalized services (MyKarger) Login Information

Please create your User ID & Password





Contact Information









I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger (new!)
  • Unrestricted printing, no saving restrictions for personal use
  • Reduced rates with a PPV account
read more

Direct: USD 38.00
Account: USD 26.50

Select

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select


Article / Publication Details

First-Page Preview
Abstract of The Peter Dukor Memorial Symposium

Published online: 9/4/2009
Issue release date: 1997

Number of Print Pages: 5
Number of Figures: 0
Number of Tables: 0

ISSN: 1018-2438 (Print)
eISSN: 1423-0097 (Online)

For additional information: http://www.karger.com/IAA

Abstract

Structural and functional analysis of the high-affinity receptor for IgE (FcεRI) on Langerhans cells (LCs) has highlighted new aspects of the biology of this structure when expressed on antigen-presenting cells. In contrast to effector cells of anaphylaxis, i.e. basophils and mast cells, where FcεRI is a tetrameric structure constitutively expressed at high levels, this receptor on LCs lacks the classical β-chain and its expression varies depending on the donor and the inflammatory environment of the cells in the skin. Although the signalling pathway seems to be similar to that of basophils or mast cells, only LCs from individuals with atopic dermatitis are fully activated by receptor ligation while LCs from normal individuals fail to exhibit calcium mobilization. LCs from normal and atopic individuals use FcεRI to maximize antigen uptake via specific IgE and subsequent presentation to T cells and may be responsible for driving the T cell response in either Th0, Th1 or Th2 type.

© 1997 S. Karger AG, Basel


  

Author Contacts

Correspondence to: Prof. Thomas Bieber, Department of Dermatology, Ludwig-Maximilians University, Frauenlobstrasse 9, D–80337 Munich (Germany)

  

Article Information

Published online: September 04, 2009
Number of Print Pages : 5

  

Publication Details

International Archives of Allergy and Immunology

Vol. 113, No. 1-3, Year 1997 (Cover Date: 1997)

Journal Editor: Valenta R. (Vienna)
ISSN: 1018-2438 (Print), eISSN: 1423-0097 (Online)

For additional information: http://www.karger.com/IAA


Article / Publication Details

First-Page Preview
Abstract of The Peter Dukor Memorial Symposium

Published online: 9/4/2009
Issue release date: 1997

Number of Print Pages: 5
Number of Figures: 0
Number of Tables: 0

ISSN: 1018-2438 (Print)
eISSN: 1423-0097 (Online)

For additional information: http://www.karger.com/IAA


Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.